43161-30-4

Basic information

• Product Name: methyl 1-(bromomethyl)cyclopropanecarboxylate
• Synonyms: methyl 1-(bromomethyl)cyclopropanecarboxylate;methyl 1-(bromomethyl)cyclopropane-1-carboxylate
• CAS NO: 43161-30-4
• Molecular Formula: C₆H₉BrO₂
• Molecular Weight: 193
• Mol File: 43161-30-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 191.6±13.0 °C(Predicted)
• Appearance: /
• Density: 1.562±0.06 g/cm3(Predicted)
• CAS DataBase Reference: methyl 1-(bromomethyl)cyclopropanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 1-(bromomethyl)cyclopropanecarboxylate(43161-30-4)
• EPA Substance Registry System: methyl 1-(bromomethyl)cyclopropanecarboxylate(43161-30-4)

Safety Data

• Hazardous Substances Data: 43161-30-4(Hazardous Substances Data)

Usage

General Description

Methyl 1-(bromomethyl)cyclopropanecarboxylate is a chemical compound with the formula C6H9BrO2. It is a cyclopropane derivative that contains both a methyl ester and a bromomethyl group. methyl 1-(bromomethyl)cyclopropanecarboxylate is commonly used in organic synthesis as a building block for creating more complex molecules. It is also used in pharmaceutical research and development, as well as in the production of agricultural chemicals. Its unique structure and reactivity make it a valuable asset in the creation of diverse chemical compounds with a wide range of potential applications.

Upstream product

• 558-13-4 carbon tetrabromide 
• 88157-42-0 methyl 1-(hydroxymethyl)cyclopropane-1-carboxylate 
• 88157-41-9 methyl 1-formylcyclopropane-1-carboxylate 

Relevant articles and documents

DIAMINE DERIVATIVES

A compound represented by formula (1):Q1-Q2-To-N(R1) -Q3-N(R2)-T1-Q4 [wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 represents the following group: (wherein Q5 is an alkylene group having 1 to 8 carbon atoms, or the like); and T0 and T1 are carbonyl groups or the like], a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

DIAMINE DERIVATIVES

A compound represented by the general formula (1):Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.